The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas

Background: Currently, the management of SARS-CoV-2 varies with no definitive clinical guidelines, as scientific evidence across the globe differs in therapeutic options. This study intended to provide some clarity to the insufficient data based on the role of monotherapy with tocilizumab (TCZ) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Almaghlouth, Nouf K, Anyiam, Felix E, Shah, Sidra, Haq, Syed, Attia, Mohamed J, Guevara, Roberto, Antony, Suresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276197/
https://www.ncbi.nlm.nih.gov/pubmed/34277310
http://dx.doi.org/10.7759/cureus.16351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276197/
https://www.ncbi.nlm.nih.gov/pubmed/34277310
http://dx.doi.org/10.7759/cureus.16351

Ejemplares similares